IE51365B1 - Antibacterial cephalosporins - Google Patents
Antibacterial cephalosporinsInfo
- Publication number
- IE51365B1 IE51365B1 IE1481/81A IE148181A IE51365B1 IE 51365 B1 IE51365 B1 IE 51365B1 IE 1481/81 A IE1481/81 A IE 1481/81A IE 148181 A IE148181 A IE 148181A IE 51365 B1 IE51365 B1 IE 51365B1
- Authority
- IE
- Ireland
- Prior art keywords
- compound
- hydrogen
- formula
- amino
- cooh
- Prior art date
Links
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 6
- 229930186147 Cephalosporin Natural products 0.000 title claims description 12
- 229940124587 cephalosporin Drugs 0.000 title claims description 12
- 150000001780 cephalosporins Chemical class 0.000 title description 6
- 238000000034 method Methods 0.000 claims abstract description 13
- 150000003839 salts Chemical class 0.000 claims abstract description 12
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 11
- 239000001257 hydrogen Substances 0.000 claims abstract description 11
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 11
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 5
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 4
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims abstract description 4
- 150000001875 compounds Chemical class 0.000 claims description 29
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 claims description 12
- -1 cephalosporin compound Chemical class 0.000 claims description 12
- 125000006239 protecting group Chemical group 0.000 claims description 5
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 claims description 4
- 239000008194 pharmaceutical composition Substances 0.000 claims description 4
- 208000035143 Bacterial infection Diseases 0.000 claims description 2
- 208000022362 bacterial infectious disease Diseases 0.000 claims description 2
- 230000000694 effects Effects 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 3
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000002360 preparation method Methods 0.000 abstract description 3
- 125000001271 cephalosporin group Chemical group 0.000 abstract 1
- 229940126062 Compound A Drugs 0.000 description 8
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 8
- 239000002253 acid Substances 0.000 description 5
- OLVCFLKTBJRLHI-AXAPSJFSSA-N cefamandole Chemical compound CN1N=NN=C1SCC1=C(C(O)=O)N2C(=O)[C@@H](NC(=O)[C@H](O)C=3C=CC=CC=3)[C@H]2SC1 OLVCFLKTBJRLHI-AXAPSJFSSA-N 0.000 description 5
- 229960003012 cefamandole Drugs 0.000 description 5
- 229960004261 cefotaxime Drugs 0.000 description 5
- AZZMGZXNTDTSME-JUZDKLSSSA-M cefotaxime sodium Chemical compound [Na+].N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C([O-])=O)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 AZZMGZXNTDTSME-JUZDKLSSSA-M 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- YGBFLZPYDUKSPT-MRVPVSSYSA-N cephalosporanic acid Chemical compound S1CC(COC(=O)C)=C(C(O)=O)N2C(=O)C[C@H]21 YGBFLZPYDUKSPT-MRVPVSSYSA-N 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 150000003573 thiols Chemical class 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- IKWLIQXIPRUIDU-ZCFIWIBFSA-N (6r)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound OC(=O)C1=CCS[C@@H]2CC(=O)N12 IKWLIQXIPRUIDU-ZCFIWIBFSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- QITDACOZCQXYQY-BAFYGKSASA-N (6r)-7-amino-5-thia-1-azabicyclo[4.2.0]oct-2-en-8-one Chemical class S1CC=CN2C(=O)C(N)[C@H]21 QITDACOZCQXYQY-BAFYGKSASA-N 0.000 description 1
- CHRJZRDFSQHIFI-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;styrene Chemical compound C=CC1=CC=CC=C1.C=CC1=CC=CC=C1C=C CHRJZRDFSQHIFI-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- COVZYZSDYWQREU-UHFFFAOYSA-N Busulfan Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical class O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000011358 absorbing material Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 239000003957 anion exchange resin Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- JUHORIMYRDESRB-UHFFFAOYSA-N benzathine Chemical class C=1C=CC=CC=1CNCCNCC1=CC=CC=C1 JUHORIMYRDESRB-UHFFFAOYSA-N 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid group Chemical group C(C1=CC=CC=C1)(=O)O WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000007972 injectable composition Substances 0.000 description 1
- 238000006317 isomerization reaction Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 125000005646 oximino group Chemical group 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N palmitic acid group Chemical group C(CCCCCCCCCCCCCCC)(=O)O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 150000002960 penicillins Chemical class 0.000 description 1
- 239000002952 polymeric resin Substances 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 229960004919 procaine Drugs 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/36—Methylene radicals, substituted by sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/165,822 US4308267A (en) | 1980-07-03 | 1980-07-03 | 7-[2-Alkoxyimino-2-(amino-thiazole)acetamido]-3-[1-(sulfaminoalkly)tetrazolthiomethyl]cephalosporins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE811481L IE811481L (en) | 1982-01-03 |
| IE51365B1 true IE51365B1 (en) | 1986-12-10 |
Family
ID=22600626
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE1481/81A IE51365B1 (en) | 1980-07-03 | 1981-07-02 | Antibacterial cephalosporins |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US4308267A (forum.php) |
| EP (1) | EP0043713B1 (forum.php) |
| JP (1) | JPS5745189A (forum.php) |
| KR (1) | KR840002046B1 (forum.php) |
| AR (1) | AR228606A1 (forum.php) |
| AT (1) | ATE9585T1 (forum.php) |
| AU (1) | AU547942B2 (forum.php) |
| CA (1) | CA1151150A (forum.php) |
| DE (1) | DE3166321D1 (forum.php) |
| DK (1) | DK286981A (forum.php) |
| ES (1) | ES8203908A1 (forum.php) |
| FI (1) | FI66876C (forum.php) |
| GR (1) | GR74363B (forum.php) |
| HU (1) | HU185934B (forum.php) |
| IE (1) | IE51365B1 (forum.php) |
| IL (1) | IL63206A (forum.php) |
| NO (1) | NO812268L (forum.php) |
| NZ (1) | NZ197573A (forum.php) |
| PH (1) | PH17670A (forum.php) |
| PT (1) | PT73292B (forum.php) |
| YU (1) | YU162481A (forum.php) |
| ZA (1) | ZA814484B (forum.php) |
| ZW (1) | ZW15181A1 (forum.php) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4526977A (en) * | 1981-10-07 | 1985-07-02 | American Home Products Corporation | 2-(3-Amino-5-isoxazolyl)-2-oxyimino-acetic acids |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4171362A (en) * | 1975-10-30 | 1979-10-16 | Smithkline Corporation | 7-Acylamino-3-(sulfaminoalkyl substituted tetrazolylthiomethyl)cephalosporins antibacterial compositions containing them and methods of treating bacterial infections with them |
| DE2760123C2 (de) * | 1976-01-23 | 1986-04-30 | Roussel-Uclaf, Paris | 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen |
| JPS52125188A (en) | 1976-04-14 | 1977-10-20 | Takeda Chem Ind Ltd | Cephalosporin derivatives and their preparation |
| US4066762A (en) * | 1976-07-12 | 1978-01-03 | Smithkline Corporation | Derivatives of 7-(2-substituted-2-hydroxyiminoacetamido)-3-(1-substituted tetrazol-5-ylthiomethyl-3-cephem-4-carboxylic acid |
| DE2714880A1 (de) * | 1977-04-02 | 1978-10-26 | Hoechst Ag | Cephemderivate und verfahren zu ihrer herstellung |
| MC1259A1 (fr) | 1978-05-30 | 1980-01-14 | Hoffmann La Roche | Derives acyles |
| US4220761A (en) * | 1978-09-12 | 1980-09-02 | Fujisawa Pharmaceutical Co., Ltd. | 7-[Substituted oximinoacetamido]-3-[hydroxy alkyltetrazolo]cephalosporin derivatives |
-
1980
- 1980-07-03 US US06/165,822 patent/US4308267A/en not_active Expired - Lifetime
-
1981
- 1981-06-29 CA CA000380845A patent/CA1151150A/en not_active Expired
- 1981-06-29 AU AU72343/81A patent/AU547942B2/en not_active Ceased
- 1981-06-29 DK DK286981A patent/DK286981A/da not_active Application Discontinuation
- 1981-06-29 JP JP56102168A patent/JPS5745189A/ja active Pending
- 1981-06-29 IL IL63206A patent/IL63206A/xx unknown
- 1981-06-30 YU YU01624/81A patent/YU162481A/xx unknown
- 1981-06-30 PH PH25836A patent/PH17670A/en unknown
- 1981-06-30 NZ NZ197573A patent/NZ197573A/en unknown
- 1981-06-30 FI FI812046A patent/FI66876C/fi not_active IP Right Cessation
- 1981-06-30 PT PT73292A patent/PT73292B/pt unknown
- 1981-06-30 GR GR65386A patent/GR74363B/el unknown
- 1981-07-01 ZW ZW151/81A patent/ZW15181A1/xx unknown
- 1981-07-02 KR KR1019810002403A patent/KR840002046B1/ko not_active Expired
- 1981-07-02 NO NO812268A patent/NO812268L/no unknown
- 1981-07-02 ES ES503622A patent/ES8203908A1/es not_active Expired
- 1981-07-02 IE IE1481/81A patent/IE51365B1/en unknown
- 1981-07-02 HU HU811934A patent/HU185934B/hu unknown
- 1981-07-02 ZA ZA814484A patent/ZA814484B/xx unknown
- 1981-07-03 EP EP81303044A patent/EP0043713B1/en not_active Expired
- 1981-07-03 AT AT81303044T patent/ATE9585T1/de not_active IP Right Cessation
- 1981-07-03 DE DE8181303044T patent/DE3166321D1/de not_active Expired
- 1981-07-03 AR AR285975A patent/AR228606A1/es active
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5745189A (en) | 1982-03-13 |
| AU7234381A (en) | 1982-01-07 |
| CA1151150A (en) | 1983-08-02 |
| GR74363B (forum.php) | 1984-06-28 |
| DK286981A (da) | 1982-01-04 |
| IL63206A (en) | 1986-09-30 |
| IE811481L (en) | 1982-01-03 |
| HU185934B (en) | 1985-04-28 |
| NZ197573A (en) | 1984-09-28 |
| DE3166321D1 (en) | 1984-10-31 |
| FI66876C (fi) | 1984-12-10 |
| FI812046L (fi) | 1982-01-04 |
| AU547942B2 (en) | 1985-11-14 |
| ZA814484B (en) | 1982-07-28 |
| EP0043713B1 (en) | 1984-09-26 |
| FI66876B (fi) | 1984-08-31 |
| NO812268L (no) | 1982-01-04 |
| ATE9585T1 (de) | 1984-10-15 |
| US4308267A (en) | 1981-12-29 |
| PH17670A (en) | 1984-11-02 |
| ES503622A0 (es) | 1982-04-01 |
| PT73292A (en) | 1981-07-01 |
| KR830006310A (ko) | 1983-09-20 |
| EP0043713A1 (en) | 1982-01-13 |
| ZW15181A1 (en) | 1981-09-29 |
| YU162481A (en) | 1983-06-30 |
| AR228606A1 (es) | 1983-03-30 |
| ES8203908A1 (es) | 1982-04-01 |
| KR840002046B1 (ko) | 1984-11-06 |
| PT73292B (en) | 1982-07-22 |
| IL63206A0 (en) | 1981-09-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4520022A (en) | Substituted vinyl cephalosporins | |
| JPS59172493A (ja) | 化合物 | |
| US5856320A (en) | Cephem compounds, their preparation and their use as antimicrobial agents | |
| US3674784A (en) | 3-formyl cephalosporin sulfoxides | |
| US5081116A (en) | Cephalosporin derivatives | |
| US4661590A (en) | Substituted vinyl cephalosporins | |
| US4103008A (en) | 7[2(2,3 Dioxopiperazin-1-yl-carbonylamino)substituted 2 phenylacetamido]-3-2'-thiadiazolyl cephalosporanic acid derivatives | |
| JPH04225985A (ja) | セフアロスポリン化合物 | |
| US4604387A (en) | 1,2,4-triazinylthiomethyl-3-cephem sulfoxides, and a procedure for their preparation | |
| EP0043713B1 (en) | Antibacterial cephalosporins | |
| US4619925A (en) | 3-Propenyl cephalosporin derivatives | |
| JPS62167784A (ja) | 新規セフアロスポリン誘導体、その製法およびそれらを有効成分とする抗菌剤 | |
| EP0188781B1 (en) | 1-oxa-1-dethia-cephalosporin compounds and antibacterial agent comprising the same | |
| JP3041309B2 (ja) | ３―置換ビニルセファロスポリン誘導体 | |
| JP2959821B2 (ja) | チアゾリルアセトアミドセフェム誘導体 | |
| JP3005273B2 (ja) | チアゾリルアセトアミド―３―セフェム系誘導体 | |
| JPH04261183A (ja) | 抗生物質ｃ−３ジヒドロキシフェニル置換セファロスポリン化合物、組成物およびそれらの使用法 | |
| EP0021688B1 (en) | 7-(thiazolylpropionamido) cephalosporins, their preparation, and pharmaceutical compositions containing them | |
| JPS6078987A (ja) | アクリルアミドセフアロスポリン類 | |
| JPS62226986A (ja) | 新規セフアロスポリン誘導体 | |
| JPH035486A (ja) | チアゾリルアセトアミドセフェム誘導体 | |
| JPH042596B2 (forum.php) | ||
| EP0321364A2 (en) | Orally administrable cephalosporin derivatives, and the production and uses thereof | |
| JPS61130293A (ja) | ふつ素化アルキルセフアロスポリン類 | |
| JPH03128382A (ja) | チアゾリルアセトアミドセフェム系化合物 |